AbbVie Inc. (ABBV)

USD 198.47

(2.65%)

Eps Summary of AbbVie Inc.

AbbVie Inc.'s latest annual eps in 2023 was 2.73 USD , down -58.95% from previous year.
AbbVie Inc.'s latest quarterly eps in 2024 Q2 was 0.78 USD , up 1.3% from previous quarter.
AbbVie Inc. reported an annual eps of 6.65 USD in 2022, up 2.62% from previous year.
AbbVie Inc. reported an annual eps of 6.48 USD in 2021, up 137.36% from previous year.
AbbVie Inc. reported a quarterly eps of 0.88 USD for 2024 Q3, up 12.82% from previous quarter.
AbbVie Inc. reported a quarterly eps of 0.78 USD for 2024 Q2, up 1.3% from previous quarter.

Annual Eps Chart of AbbVie Inc. (2023 - 2009)

Historical Annual Eps of AbbVie Inc. (2023 - 2009)

Year	Eps	Eps Growth
2023	2.73 USD	-58.95%
2022	6.65 USD	2.62%
2021	6.48 USD	137.36%
2020	2.73 USD	-48.49%
2019	5.30 USD	43.63%
2018	3.69 USD	11.48%
2017	3.31 USD	-9.32%
2016	3.65 USD	15.87%
2015	3.15 USD	183.78%
2014	1.11 USD	-56.98%
2013	2.58 USD	-22.99%
2012	3.35 USD	58.02%
2011	2.12 USD	-18.15%
2010	2.59 USD	-9.76%
2009	2.87 USD	0.0%

Year	Eps	Eps Growth
2024 Q1	0.77 USD	67.39%
2024 Q3	0.88 USD	12.82%
2024 Q2	0.78 USD	1.3%
2023 Q2	1.14 USD	776.92%
2023 Q4	0.46 USD	-54.0%
2023 FY	- USD	-58.95%
2023 Q1	0.13 USD	-90.71%
2023 Q3	1.00 USD	-12.28%
2022 Q1	2.54 USD	10.92%
2022 Q3	2.23 USD	328.85%
2022 Q4	1.40 USD	-37.22%
2022 FY	- USD	2.62%
2022 Q2	0.52 USD	-79.53%
2021 Q2	0.42 USD	-79.0%
2021 Q3	1.78 USD	323.81%
2021 Q4	2.29 USD	28.65%
2021 FY	- USD	137.36%
2021 Q1	2.00 USD	9703.92%
2020 Q3	1.30 USD	388.89%
2020 Q4	0.02 USD	-98.43%
2020 FY	- USD	-48.49%
2020 Q2	-0.45 USD	-122.28%
2020 Q1	2.02 USD	6.88%
2019 FY	- USD	43.63%
2019 Q1	1.65 USD	235.25%
2019 Q2	0.49 USD	-70.3%
2019 Q3	1.27 USD	159.18%
2019 Q4	1.89 USD	48.82%
2018 Q1	1.74 USD	5221.1%
2018 FY	- USD	11.48%
2018 Q4	-1.22 USD	-167.4%
2018 Q3	1.81 USD	43.65%
2018 Q2	1.26 USD	-27.59%
2017 Q1	1.07 USD	22.99%
2017 FY	- USD	-9.32%
2017 Q4	0.03 USD	-96.79%
2017 Q2	1.20 USD	12.15%
2017 Q3	1.02 USD	-15.0%
2016 Q3	0.97 USD	-2.02%
2016 Q4	0.87 USD	-10.31%
2016 FY	- USD	15.87%
2016 Q1	0.83 USD	-11.7%
2016 Q2	0.99 USD	19.28%
2015 Q3	0.75 USD	-10.71%
2015 FY	- USD	183.78%
2015 Q4	0.94 USD	25.33%
2015 Q2	0.84 USD	31.25%
2015 Q1	0.64 USD	225.49%
2014 Q2	0.69 USD	13.11%
2014 Q1	0.61 USD	-14.08%
2014 FY	- USD	-56.98%
2014 Q4	-0.51 USD	-259.38%
2014 Q3	0.32 USD	-53.62%
2013 Q4	0.71 USD	18.33%
2013 Q3	0.60 USD	-10.45%
2013 Q2	0.67 USD	9.84%
2013 Q1	0.61 USD	-37.11%
2013 FY	- USD	-22.99%
2012 Q1	0.55 USD	-24.66%
2012 FY	- USD	58.02%
2012 Q2	0.78 USD	41.82%
2012 Q3	1.00 USD	28.21%
2012 Q4	0.97 USD	-3.0%
2011 Q1	0.45 USD	0.0%
2011 Q3	0.01 USD	-99.2%
2011 Q4	0.73 USD	9258.97%
2011 Q2	0.97 USD	115.56%
2011 FY	- USD	-18.15%
2010 FY	- USD	-9.76%
2009 FY	- USD	0.0%

Peer Eps Comparison of AbbVie Inc.

Name	Eps	Eps Difference
Bristol-Myers Squibb Company	3.88 USD	29.639%
Bristol-Myers Squibb Company Ce	3.88 USD	29.639%
Johnson & Johnson	13.88 USD	80.331%
Eli Lilly and Company	5.80 USD	52.931%
Merck & Co., Inc.	0.14 USD	-1850.0%
Novartis AG	7.15 USD	61.818%
Organon & Co.	4.01 USD	31.92%
Pfizer Inc.	0.38 USD	-618.421%